NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets ...
In an intriguing turn of events, NovaBay Pharmaceuticals, Inc. (NYSE: NBY) has captured market attention with a remarkable surge of 50.97%, reaching $0.7502 during the Friday trading session at 11:17 ...
NovaBay Pharmaceuticals (NBY) has entered into a definitive asset purchase agreement with PRN Physician Recommended Nutriceuticals, ...
Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye ...
EMERYVILLE, Calif. - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY)宣布以950万美元的现金交易将其Avenova品牌出售给PRN Physician Recommended Nutriceuticals, LLC。该交易预计将在2024年第四季度完成,但需满足惯例成交条件并获得NovaBay股东的批准。 NovaBay的首 ...
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces it has entered into a definitive asset purchase agreement (the "Agreement") with PRN Physician Recommended ...